DNA Patent Question Tossed Back To Lower Court
In the wake of the high court’s ruling in Mayo v. Prometheus, the Supreme Court orders the Federal Circuit to reconsider its decision that Myriad Genetics’ isolated BRCA genes are patentable.
In the wake of the high court’s ruling in Mayo v. Prometheus, the Supreme Court orders the Federal Circuit to reconsider its decision that Myriad Genetics’ isolated BRCA genes are patentable.